MedPath

An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study

Recruiting
Conditions
Morbid Obesity
Registration Number
NCT02811900
Lead Sponsor
IHU Strasbourg
Brief Summary

A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization.

A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group).

Detailed Description

A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization. Patients were evaluated by a multidisciplinary team. The standard preoperative assessment included nutritional counseling, psychological evaluation, abdominal ultrasound, upper gastrointestinal endoscopy, and blood tests. Type and date of surgery, biological and clinical follow-up data and morbidity data were recorded prospectively in the database.

A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group). Patients who had IH were paired with patients of the same age and sex and at the same postoperative interval. Paired patients were contacted by phone to obtain the QoL questionnaires, abdominal pain evaluation, and weight loss data.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • patient >18 years old
  • BMI > 35 kg/m²
Exclusion Criteria
  • Incapacity of giving an informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Excess weight loss1 - 3 - 5 - 10 - 15 and 30 years
Secondary Outcome Measures
NameTimeMethod
Serum insulin1 - 3 - 5 - 10 - 15 and 30 years

Serum insulin

BMI1 - 3 - 5 - 10 - 15 and 30 years
Albumin1 - 3 - 5 - 10 - 15 and 30 years

Albumin

Vitamin A1 - 3 - 5 - 10 - 15 and 30 years

Vitamin A

Postoperative morbidity1 - 3 - 5 - 10 - 15 and 30 years

Postoperative morbidity

Pre-albumin1 - 3 - 5 - 10 - 15 and 30 years

Pre-albumin

Vitamin B121 - 3 - 5 - 10 - 15 and 30 years

Vitamin B12

Fasting plasma glucose1 - 3 - 5 - 10 - 15 and 30 years

Fasting plasma glucose

HbA1c1 - 3 - 5 - 10 - 15 and 30 years

HbA1c

Triglycerides1 - 3 - 5 - 10 - 15 and 30 years

Triglycerides

Cholesterol1 - 3 - 5 - 10 - 15 and 30 years

Cholesterol (total, HDL, LDL)

Vitamin B61 - 3 - 5 - 10 - 15 and 30 years

Vitamin B6

Quality of life assessed by Moorehead-Ardelt Quality of life II questionnaire1 - 3 - 5 - 10 - 15 and 30 years

Moorehead-Ardelt Quality of life II questionnaire

Vitamin B91 - 3 - 5 - 10 - 15 and 30 years

Vitamin B9

Plasma ferritin1 - 3 - 5 - 10 - 15 and 30 years

Plasma ferritin

Quality of life assessed by Gastro-intestinal Quality of Life Index1 - 3 - 5 - 10 - 15 and 30 years

Gastro-intestinal Quality of Life Index

Vitamin D1 - 3 - 5 - 10 - 15 and 30 years

Vitamin D

Trial Locations

Locations (1)

Service de Chirurgie Digestive et Endocrinienne

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath